| 000 | 01777 a2200517 4500 | ||
|---|---|---|---|
| 005 | 20250513041031.0 | ||
| 264 | 0 | _c19950511 | |
| 008 | 199505s 0 0 eng d | ||
| 022 | _a0167-8140 | ||
| 024 | 7 |
_a10.1016/0167-8140(94)90062-0 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aThomas, L | |
| 245 | 0 | 0 |
_aIntraoperative interstitial iridium brachytherapy in the management of soft tissue sarcomas: preliminary results of a feasibility phase II study. _h[electronic resource] |
| 260 |
_bRadiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology _cNov 1994 |
||
| 300 |
_a99-105 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Clinical Trial, Phase II; Journal Article | ||
| 650 | 0 | 4 | _aAdolescent |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aAged, 80 and over |
| 650 | 0 | 4 |
_aBrachytherapy _xadverse effects |
| 650 | 0 | 4 | _aChild |
| 650 | 0 | 4 | _aFeasibility Studies |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aIntraoperative Period |
| 650 | 0 | 4 | _aIridium |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aNeoplasm Recurrence, Local _xmortality |
| 650 | 0 | 4 | _aPrognosis |
| 650 | 0 | 4 | _aRadioisotopes |
| 650 | 0 | 4 | _aRadiotherapy, Adjuvant |
| 650 | 0 | 4 |
_aSarcoma _xmortality |
| 650 | 0 | 4 | _aSurvival Rate |
| 700 | 1 | _aDelannes, M | |
| 700 | 1 | _aStöckle, E | |
| 700 | 1 | _aMartel, P | |
| 700 | 1 | _aBui, B N | |
| 700 | 1 | _aDaly-Schveitzer, N | |
| 700 | 1 | _aPigneux, J | |
| 700 | 1 | _aChevreau, C | |
| 700 | 1 | _aKantor, G | |
| 773 | 0 |
_tRadiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology _gvol. 33 _gno. 2 _gp. 99-105 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/0167-8140(94)90062-0 _zAvailable from publisher's website |
| 999 |
_c7708354 _d7708354 |
||